News and Announcements

Hikma reiterates outlook on strong trading

By Abigail Townsend

Date: Thursday 07 Nov 2024

(Sharecast News) - Hikma Pharmaceuticals reiterated its full-year outlook on Thursday on the back of strong trading across the business.
Updating on current trading, the blue chip said it was "performing well", leaving it on track to grow 2024 revenue by between 6% and 8%. Core operating profit is forecast to...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page